fully human monoclonal antibody specific for lymphocyte activation gene 3 and nivolumab

fully human monoclonal antibody specific for lymphocyte activation gene 3 and nivolumab
Trade Name
Orphan Indication Metastatic Melanoma
USA Market Approval USA
USA Designation Date 2017-08-18 00:00:00
Sponsor Bristol-Myers Squibb Co.;5 Research Parkway;Wallingford, Connecticut, 06492
Related Access Program
Merck Sharp & Dohme Corp. – Metastatic Melanoma Eli Lilly and Company – Metastatic Melanoma Bristol-Myers Squibb – Metastatic Melanoma Bristol-Myers Squibb – Metastatic Melanoma